This inventor holds 9 USPTO granted patents and 4 published patent applications and 2 EPO patents. Top assignees: International Aids Vaccine Initiative, Merck Sharp + Dohme Corp.. Active years: 2016-2025.
Location History:
- New York, NY (US) (2019 - 2020)
- Brooklyn, NY (US) (2016 - 2023)
Company Filing History:
9 out of 71 
1 out of 2,405 
Years Active: 2016-2025
Title: Maoli Yuan: Innovator in Vaccine Development
Introduction
Maoli Yuan is a prominent inventor based in Brooklyn, NY, known for his significant contributions to the field of vaccine development. With a total of 9 patents to his name, Yuan has been at the forefront of innovative solutions aimed at combating infectious diseases.
Latest Patents
Yuan's latest patents include groundbreaking work on replication-competent attenuated chimeric VSV vectors encoding immunogenic SARS-CoV-2 spike proteins. This patent provides a novel approach to developing vaccines against Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2). The technology involves recombinant vesicular stomatitis virus (VSV) vectors that encode the SARS-CoV-2 spike (S) protein or its immunogenic variants. These recombinant VSV particles are designed to induce an immune response, prevent infection, and facilitate the production of adaptive mutants. Another notable patent focuses on the preparation and purification of immunogenic compositions for use as prophylactic and therapeutic vaccines.
Career Highlights
Throughout his career, Maoli Yuan has worked with esteemed organizations such as the International Aids Vaccine Initiative and Merck Sharp & Dohme Corp. His experience in these companies has allowed him to contribute to significant advancements in vaccine research and development.
Collaborations
Yuan has collaborated with notable colleagues, including Christopher Lee Parks and Kevin Wright, further enhancing the impact of his work in the field of immunology.
Conclusion
Maoli Yuan's innovative work in vaccine development, particularly in relation to SARS-CoV-2, showcases his dedication to advancing public health. His contributions are vital in the ongoing fight against infectious diseases, and his patents reflect a commitment to scientific excellence.